IL1B and central nervous system cancer: TAMs have been shown to release a plethora of factors that stimulate tumor growth and invasion, including TGF-β, IL-1β, IL-6, stress-inducible protein 1 (STI1), and epidermal growth factor (EGF) by acting on GSCs in the perivascular niche and glioma cells.